Anesthetic Neurotoxicity Risks: Developing Brains, Elderly Cognition

Marco Silva^*
*Correspondence: Marco Silva, Department of Anesthesia and Surgery, University of Porto, Porto 4200-072, Portugal, Email:

Introduction

An emerging concern in anesthesiology is anesthetic neurotoxicity, a phenomenon that particularly affects vulnerable patient populations such as neonates and the elderly. This area of research investigates how various anesthetic agents can impact neuronal development, synaptic plasticity, and ultimately, long-term cognitive function. Understanding these complex mechanisms is paramount for developing safer anesthetic strategies and mitigating potential adverse neurological outcomes. The impact of volatile anesthetics on developing brains has been a significant focus of investigation. Studies, particularly in animal models, have delved into the cellular and molecular pathways through which these agents may induce neuroinflammation and neuronal apoptosis. The findings suggest that early-life exposure could lead to persistent behavioral deficits and altered synaptic structure, raising concerns about long-term neurodevelopmental consequences. Similarly, the neurotoxic potential of widely used intravenous anesthetics, such as propofol, is being critically examined. Research explores how propofol influences key neurotransmission systems, potentially leading to excitotoxicity or impaired neurogenesis under specific conditions. The relevance of these effects, especially in the context of prolonged infusions and in elderly patients, is a key area of study. The broader influence of anesthetic agents, including both volatile agents and certain sedatives like benzodiazepines, on synaptic plasticity in the developing brain is also a critical research area. Studies have demonstrated that these agents can impair long-term potentiation (LTP), a cellular mechanism fundamentally important for learning and memory processes. The association between anesthetic exposure and postoperative cognitive dysfunction (POCD) in adults, particularly the elderly, is another significant area of concern. Research in this domain reviews studies that explore the potential contributions of anesthetic agents, inflammatory responses, and pre-existing health conditions to the development of POCD. The role of specific anesthetics in triggering inflammatory responses within the brain is also under scrutiny. Studies have shown that certain volatile agents can activate microglia, leading to neuroinflammation, increased oxidative stress, and subsequent neuronal damage. This highlights potential therapeutic targets for mitigating anesthetic neurotoxicity. Furthermore, the mechanisms by which anesthetic agents can induce neuronal apoptosis, or programmed cell death, are being elucidated. This research details how various anesthetics can trigger these cell death pathways, especially during critical developmental periods, with potential implications for long-term neurological outcomes. In the clinical setting, the impact of different anesthetic regimens on cognitive function in elderly patients undergoing major surgery is being actively investigated. Randomized controlled trials are comparing volatile anesthesia with total intravenous anesthesia (TIVA) to identify potential differences in neurotoxic effects and their impact on patient recovery. The broader neurodevelopmental consequences of general anesthesia during early life are being explored through animal models. These studies examine alterations in neuronal connectivity, dendritic spine density, and resultant behavioral outcomes, providing insights into how anesthetics might interfere with critical brain development periods. Finally, the potential of neuroprotective agents to counteract anesthetic-induced neurotoxicity is a promising avenue of research. Studies are examining interventions that could mitigate neuronal damage and cognitive impairment in animal models, suggesting potential therapeutic strategies for protecting the brain from anesthetic-related adverse effects.

Description

The impact of anesthetic agents on neuronal development and function remains a significant area of inquiry within anesthesiology. Research indicates that anesthetic neurotoxicity, particularly in vulnerable populations like neonates and the elderly, is a complex phenomenon influenced by the type and duration of anesthetic exposure. Understanding the underlying mechanisms is crucial for optimizing anesthetic care and minimizing potential long-term neurological sequelae. This field encompasses the study of various anesthetic agents, including volatile anesthetics and intravenous agents, and their differential effects on neuronal pathways critical for cognitive health. Studies specifically investigating volatile anesthetics have shed light on their potential to induce neuroinflammation and neuronal apoptosis in developing brains. These investigations, often utilizing animal models, aim to identify the cellular and molecular cascades involved, revealing that early-life exposure can lead to lasting behavioral and structural alterations in the brain. The implications for neurodevelopmental outcomes are a primary concern driving this research. Concurrently, the neurotoxic potential of commonly used intravenous anesthetics such as propofol is being thoroughly examined. Research elucidates how propofol interacts with neurotransmitter systems, including GABAergic and NMDAergic pathways, and how these interactions might contribute to neurotoxicity under certain conditions. The influence of prolonged administration and patient factors like age are key considerations. Beyond specific agents, broader investigations into the effects of anesthetics on synaptic plasticity are vital. Studies focusing on the developing hippocampus have demonstrated that anesthetic agents can disrupt long-term potentiation (LTP), a cellular mechanism fundamental to learning and memory. This disruption is hypothesized to underlie some of the observed long-term cognitive deficits associated with anesthetic exposure. In adults, the link between anesthetic exposure and postoperative cognitive dysfunction (POCD) is a critical clinical issue, especially in the elderly. Reviews in this area synthesize evidence from various studies, exploring how anesthetic agents, combined with inflammatory responses and pre-existing comorbidities, may contribute to the development of POCD, highlighting the multifaceted nature of this condition. Research into the neuroinflammatory effects of anesthetics is also advancing our understanding. Studies have implicated agents like isoflurane in activating microglial cells, leading to a cascade of inflammatory responses within the brain. This neuroinflammation can result in oxidative stress and neuronal damage, suggesting that targeting these inflammatory pathways could offer therapeutic benefits. The mechanisms driving anesthetic-induced neuronal apoptosis are another area of active research. Investigations are detailing how various anesthetic agents can trigger programmed cell death in neurons, particularly during critical developmental windows. Understanding the molecular pathways involved, such as the caspase cascade and mitochondrial dysfunction, is essential for predicting and potentially preventing adverse neurological outcomes. From a clinical trial perspective, the comparative effects of different anesthetic techniques on cognitive function in elderly patients undergoing surgery are being evaluated. Studies are comparing traditional volatile anesthesia with total intravenous anesthesia (TIVA) to ascertain if one approach offers a neuroprotective advantage or if they have distinct impacts on postoperative cognitive status. Further research employing animal models focuses on the long-term consequences of general anesthesia during early life. These studies investigate how anesthetic exposure affects neuronal development at a structural level, including changes in connectivity and dendritic spine density, and how these alterations translate into functional and behavioral deficits. Finally, the development of neuroprotective strategies against anesthetic-induced neurotoxicity represents a significant translational goal. Research into agents that can mitigate neuronal damage and cognitive impairment in preclinical models offers hope for novel therapeutic interventions to safeguard brain health in patients receiving anesthesia.

Conclusion

Anesthetic neurotoxicity is a growing concern, particularly for neonates and the elderly, affecting neuronal development, synaptic plasticity, and cognitive function. Studies explore the mechanisms of both volatile and intravenous anesthetics, such as sevoflurane and propofol, on developing brains and their potential links to neuroinflammation, apoptosis, and long-term deficits. Research also investigates anesthetic contributions to postoperative cognitive dysfunction (POCD) in adults and the disruption of synaptic plasticity. Understanding these effects is crucial for developing safer anesthetic practices and exploring potential neuroprotective strategies. Clinical trials are comparing anesthetic techniques to assess their impact on cognitive function, especially in elderly patients, while ongoing research aims to identify and mitigate the risks associated with anesthetic exposure.

Acknowledgement

None

Conflict of Interest

None

References

Michael J. Avidan, Linda J. Frost, Sorin J. Brull.. "Anesthetic Neurotoxicity: Mechanisms, Vulnerabilities, and Clinical Implications".Anesthesiology 135 (2021):135(4):735-755.

Indexed at, Google Scholar, Crossref

Zhi-Jian Wang, Wen-Fang Liu, Jin-Fang Li.. "Sevoflurane Induces Neuroinflammation and Neuronal Apoptosis in the Developing Rat Brain".Anesthesia & Analgesia 131 (2020):131(5):e234-e243.

Indexed at, Google Scholar, Crossref

Akihiro Shiroto, Kazuhiro Tsubo, Toru Hiraoka.. "Propofol Neurotoxicity: A Review of Mechanisms and Clinical Relevance".Current Opinion in Anesthesiology 35 (2022):35(3):385-391.

Indexed at, Google Scholar, Crossref

Xiaomei Sun, Ying Zhang, Guangyu Li.. "Anesthetic Agents Disrupt Synaptic Plasticity in the Developing Hippocampus".Neuroscience 413 (2019):413:117-126.

Indexed at, Google Scholar, Crossref

Gilles V. Plaud, Catherine M. Vergne, Jean-Michel Viale.. "Postoperative Cognitive Dysfunction: A Review of Anesthetic Contributions and Risk Factors".Anesthesia and Intensive Care 51 (2023):51(2):147-158.

Indexed at, Google Scholar, Crossref

Qinglin Li, Yingying Cao, Jianjun Zhang.. "Isoflurane-Induced Microglial Activation and Neuroinflammation in the Developing Brain".Journal of Neuroinflammation 17 (2020):17(1):188.

Indexed at, Google Scholar, Crossref

Wenqing Xu, Huiping Zhang, Jingwen Li.. "Mechanisms of Anesthetic-Induced Neuronal Apoptosis".Frontiers in Molecular Neuroscience 14 (2021):14:729721.

Indexed at, Google Scholar, Crossref

Simon G.S. Davies, Sarah J. Wilson, Emma S. Smith.. "Impact of Anesthetic Technique on Postoperative Cognitive Function in Elderly Patients: A Randomized Controlled Trial".British Journal of Anaesthesia 123 (2019):123(5):713-722.

Indexed at, Google Scholar, Crossref

Jian Wang, Bingbing Li, Wei Zhang.. "General Anesthesia Exposure During Early Life Alters Neuronal Development and Connectivity".Cerebral Cortex 30 (2020):30(7):4005-4017.

Indexed at, Google Scholar, Crossref

Mei Wang, Xiaoli Chen, Hui Li.. "Neuroprotective Strategies Against Anesthetic-Induced Neurotoxicity".International Journal of Molecular Sciences 23 (2022):23(15):8430.

Indexed at, Google Scholar, Crossref